Medtronic plc (MDT:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends
Company Report I 2024-08-12 I 103 Pages I Quaintel Research
Report Summary
Medtronic plc (MDT:NYSE) Strategic SWOT, PESTLE Analysis and Financial Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Trends Report is a comprehensive and easily accessible overview of Medtronic plc's business operations. It provides a detailed analysis of the company's financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Medtronic plc including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Medtronic plc's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company's operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Medtronic plc's overall strategic standing and supports informed decision-making and strategic planning.
The report also covers Medtronic plc's financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Medtronic plc's financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors' operations.
Finally, the report includes recent news and deal activities undertaken by Medtronic plc enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Medtronic plc is a leading global medical technology company, headquartered in Dublin, Ireland. Established in 1949, the company has grown to become a pioneer in developing and manufacturing a broad range of innovative medical devices and therapies. Medtronic focuses on improving patient outcomes through its extensive portfolio, which includes products for cardiovascular, diabetes, neurological, and surgical conditions. The company's key segments include Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. Medtronic is known for its commitment to advancing medical technology and enhancing patient care through groundbreaking research and development. With a presence in over 150 countries, Medtronic's global reach and comprehensive product offerings aim to address some of the most challenging healthcare needs worldwide. The company's mission is to alleviate pain, restore health, and extend life through its innovative solutions, driven by a dedication to improving th
Medtronic plc in the News:-
- 07-Aug-2024 - Medtronic announces FDA approval of Simplera CGM and global partnership with Abbott
- 26-Jun-2024 - Medtronic announces departure of Karen Parkhill, Chief Financial Officer
- 21-Jun-2024 - Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
- 20-May-2024 - MiniMed 780G system recognized among Fast Company's 2024 World Changing Ideas
- 17-May-2024 - Medtronic Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company's future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Medtronic plc's internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Medtronic plc:
- Medtronic plc Value Chain Analysis
- Medtronic plc Porter's Five Forces Analysis
- Medtronic plc VRIO Analysis
- Medtronic plc BCG Analysis
- Medtronic plc Segmentation, Targeting and Positioning (STP) Analysis
- Medtronic plc Ansoff Matrix Analysis
Table of Contents
COMPANY EXECUTIVE SUMMARY 1
Table of Contents 2
Tables 6
Charts 7
Medtronic plc - Key Company Facts 8
Medtronic plc - Company Description 9
Medtronic plc - Top Executives 10
Medtronic plc- Top Executives Biographies 12
Medtronic plc- Head Office & Locations 16
Head Office - Country 16
Key Subsidiaries 17
Key Joint Ventures 19
Medtronic plc - Products and Services 20
Products 20
Services 22
Medtronic plc - Historic Events 23
Medtronic plc - Company's Management Discussion 24
Medtronic plc - Company's Mission and Vision 32
Mission 32
Medtronic plc - Corporate Strategy 33
Medtronic plc - Business Description 36
Cardiovascular Portfolio 37
Medical Surgical Portfolio 38
Neuroscience Portfolio 38
Diabetes Operating Unit 39
Medtronic plc - ESG Spotlight 40
Environment 40
Social 40
Corporate Governance 40
Medtronic plc - SWOT Analysis 42
Overview 42
Strengths 44
Weaknesses 47
Opportunities 48
Threats 50
Medtronic plc - PESTLE Analysis 53
Overview 53
Political Factors 55
Economic Factors 57
Social Factors 58
Technological Factors 60
Legal Factors 61
Environmental Factors 63
Medtronic plc - Financial Deep Dive 65
Share Price Trend - Aug-2023 to Aug-2024 (Average Share Closing Price) 65
Profit and Loss Statement 67
Balance Sheet 68
Cash Flow Statement 69
Key Financial Ratio Analysis 70
Medtronic plc - Ratio Charts 71
Activity Ratio Charts 71
Growth Ratios Charts 72
Leverage Ratio Charts 73
Liquidity Ratio Charts 74
Profitability Ratio Charts 75
Competing Players 76
Snapshot of Competing Players 77
Baxter International Inc. 77
Key Company Facts 77
Company Description 77
Snapshot of Competing Players 79
Becton, Dickinson and Company 79
Key Company Facts 79
Company Description 79
Snapshot of Competing Players 81
Boston Scientific Corporation 81
Key Company Facts 81
Company Description 81
Snapshot of Competing Players 83
Hologic Inc 83
Key Company Facts 83
Company Description 83
Snapshot of Competing Players 85
Johnson & Johnson 85
Key Company Facts 85
Company Description 85
Medtronic plc - In the News 87
07-Aug-2024 - Medtronic announces FDA approval of Simplera CGM and global partnership with Abbott 87
26-Jun-2024 - Medtronic announces departure of Karen Parkhill, Chief Financial Officer 89
21-Jun-2024 - Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference 90
20-May-2024 - MiniMed 780G system recognized among Fast Company's 2024 World Changing Ideas 91
17-May-2024 - Medtronic Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment 92
Medtronic plc - Key Deals 95
25-May-2023 - Medtronic to acquire wearable insulin patch maker EOFlow 95
Appendix 97
Definitions 97
SWOT Analysis 97
PESTLE Analysis 97
Value Chain Analysis 97
ESG Spotlight 97
Financial Deep Dive 97
Financial Ratios - 98
Activity Ratios 98
Growth Ratios 99
Leverage Ratios 100
Liquidity Ratios 101
Market Ratios 102
Profitability Ratios 102
Research Methodology 103
Disclaimer 104
Contact Us 104
Tables
Table 1: Medtronic plc - Company Facts
Table 2: Medtronic plc - Top Executives
Table 3: Medtronic plc - Top Executives Biographies
Table 4: Medtronic plc - Subsidiaries
Table 5: Medtronic plc - Key Joint Ventures
Table 6: Medtronic plc - Products
Table 7: Medtronic plc - Services
Table 8: Medtronic plc - Historic Events
Table 9: Medtronic plc - Share Price Trend - Aug-2023 to Aug-2024
Table 10: Medtronic plc - Ratio Analysis - 2021-2024
Table 11: Medtronic plc - Competing Players
Charts
Figure 1: Medtronic plc- SWOT Analysis 43
Figure 2: Medtronic plc - PESTLE Analysis 54
Figure 3: Medtronic plc - Average Share Price Trend - Aug-2023 to Aug-2024 66
Figure 4: Medtronic plc - Profit and Loss Statement - 2021-2024 67
Figure 5: Medtronic plc - Balance Sheet - 2021-2024 68
Figure 6: Medtronic plc - Cash Flow Statement 2021-2024 69
Figure 7: Medtronic plc - Activity Ratio Charts 71
Figure 8: Medtronic plc - Growth Ratio Charts (Value %) 72
Figure 9: Medtronic plc - Leverage Ratio Charts 73
Figure 10: Medtronic plc - Liquidity Ratio Charts 74
Figure 11: Medtronic plc - Profitability Ratio Charts (Value %) 75
Figure 12: Competing Players - Baxter International Inc. - Key Financials 78
Figure 13: Competing Players - Becton, Dickinson and Company - Key Financials 80
Figure 14: Competing Players - Boston Scientific Corporation - Key Financials 82
Figure 15: Competing Players - Hologic Inc - Key Financials 84
Figure 16: Competing Players - Johnson & Johnson - Key Financials 86
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.